Home›Companies›Biotech & Pharma›Boston Interactome

Boston Interactome, Inc.

Maps protein interactions in cells to support more targeted therapies.

Updated Nov 10, 2026·Latest SEC filing Jun 24, 2026·Suggest an edit

About Boston Interactome

Boston Interactome is a private company based in Allston, Massachusetts, incorporated in 2025 in Delaware. It has reported $500,000 raised in one offering on Form D since June 2026. Its chief executive is Oliver Weisser.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 18, 2026Jun 24, 2026$500,000of $1.5M target1$500KOptions, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Boston Interactome's Form D filed Jun 24, 2026.

SC
Soon Gang Choi
Executive officer and director
OW
Oliver Weisser
Chief Executive Officer and director

Sources

  1. SECBoston Interactome, Inc. filing history